Literature DB >> 17627061

HPV infection in men.

Joel M Palefsky1.   

Abstract

While much is known about the natural history of cervical human papillomavirus (HPV) infection and its consequences, including cervical intraepithelial neoplasia and cervical cancer, relatively little is known about the natural history of anogenital HPV infection and diseases in men. In part this reflects difficulties in penile sampling and visual assessment of penile lesions. Anal HPV infection and disease also remain poorly understood. Although HPV is transmitted sexually and infects the genitals of both sexes, the cervix remains biologically more vulnerable to malignant transformation than does the penis or anus in men. An understanding of male HPV infection is therefore important in terms of reducing transmission of HPV to women and improving women's health. However, it is also important due to the burden of disease in men, who may develop both penile and anal cancer, particularly among HIV-positive men who have sex with men. Improved sampling techniques of the male genitalia and cohort studies in progress should provide important information on the natural history of anogenital HPV infection and disease in men, including risk factors for HPV acquisition and transmission. The impact of HPV vaccination in women on male anogenital HPV infection will also need to be assessed.

Entities:  

Mesh:

Year:  2007        PMID: 17627061      PMCID: PMC3851123          DOI: 10.1155/2007/159137

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  20 in total

1.  Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.

Authors:  Anna R Giuliano; Joel M Palefsky; Stephen Goldstone; Edson D Moreira; Mary E Penny; Carlos Aranda; Eftyhia Vardas; Harald Moi; Heiko Jessen; Richard Hillman; Yen-Hwa Chang; Daron Ferris; Danielle Rouleau; Janine Bryan; J Brooke Marshall; Scott Vuocolo; Eliav Barr; David Radley; Richard M Haupt; Dalya Guris
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

2.  The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection.

Authors:  Luis F Barroso
Journal:  Ther Adv Vaccines       Date:  2013-07

3.  Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

Authors:  Chelse Spinner; Lili Ding; David I Bernstein; Darron R Brown; Eduardo L Franco; Courtney Covert; Jessica A Kahn
Journal:  Pediatrics       Date:  2019-01-22       Impact factor: 7.124

4.  Quality of life of homosexual males with genital warts: a qualitative study.

Authors:  Gitte Lee Mortensen; Helle K Larsen
Journal:  BMC Res Notes       Date:  2010-11-04

5.  Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men.

Authors:  Danielle M Backes; Maaike C G Bleeker; Chris J L M Meijer; Michael G Hudgens; Kawango Agot; Robert C Bailey; J O Ndinya-Achola; Juma Hayombe; Cornelis J A Hogewoning; Stephen Moses; Peter J F Snijders; Jennifer S Smith
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

6.  CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women.

Authors:  Hung N Luu; E Susan Amirian; Wenyaw Chan; R Palmer Beasley; Linda B Piller; Michael E Scheurer
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

7.  Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.

Authors:  Richard J Hillman; Anna R Giuliano; Joel M Palefsky; Stephen Goldstone; Edson D Moreira; Eftyhia Vardas; Carlos Aranda; Heiko Jessen; Daron G Ferris; Francois Coutlee; J Brooke Marshall; Scott Vuocolo; Richard M Haupt; Dalya Guris; Elizabeth I O Garner
Journal:  Clin Vaccine Immunol       Date:  2011-12-07

8.  Characterization of the human papillomavirus (HPV) integration sites into genital cancers.

Authors:  Clorinda Annunziata; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Pathol Oncol Res       Date:  2012-03-27       Impact factor: 3.201

9.  Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation.

Authors:  Mina Kalantari; Luisa L Villa; Itzel E Calleja-Macias; Hans-Ulrich Bernard
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

Review 10.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.